VYNE Therapeutics (VYNE) EBIT Margin Growth (3y) (2020 - 2026)
VYNE Therapeutics (VYNE) EBIT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | 143,779.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,779.00 |
| Jun 30, 2025 | -96,502.00 |
| Mar 31, 2025 | 28,408.00 |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -272,352.00 |
| Jun 30, 2024 | -201,593.00 |
| Mar 31, 2024 | -313,783.00 |
| Dec 31, 2023 | -847,643.00 |
| Sep 30, 2023 | -474,982.00 |
| Jun 30, 2023 | -888,767.00 |
| Mar 31, 2023 | -359,563.00 |
| Dec 31, 2022 | 19,563.00 |
| Mar 31, 2022 | 27,456.00 |
| Dec 31, 2021 | -379,100.00 |
| Jun 30, 2021 | -314,414.00 |
| Mar 31, 2021 | -158,221.00 |
| Dec 31, 2020 | -17,153.00 |
| Sep 30, 2020 | 19,834.00 |
| Jun 30, 2020 | -4,392.00 |
| Mar 31, 2020 | -104,218.00 |